-
1
-
-
73849096461
-
Resolution of macular edema in Coats' disease with intravitreal bevacizumab
-
Entezari M., Ramezani A., Safavizadeh L., Bassirnia N. Resolution of macular edema in Coats' disease with intravitreal bevacizumab. Indian J. Ophthalmol. 2010, 58:80-82.
-
(2010)
Indian J. Ophthalmol.
, vol.58
, pp. 80-82
-
-
Entezari, M.1
Ramezani, A.2
Safavizadeh, L.3
Bassirnia, N.4
-
2
-
-
33845745774
-
Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema
-
Issue
-
Haritoglou C., Kook D., Neubauer A., Wolf A., Priglinger S., Strauss R. Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema. Retina 2006, 26:999-1005. Issue.
-
(2006)
Retina
, vol.26
, pp. 999-1005
-
-
Haritoglou, C.1
Kook, D.2
Neubauer, A.3
Wolf, A.4
Priglinger, S.5
Strauss, R.6
-
3
-
-
55449105439
-
Efficacy of intravitreal injection of bevacizumab for severe retinopathy of prematurity: a pilot study
-
Kusaka S., Shima C., Wada K., Arahori H., Shimojyo H., Sato T., Fujikado T. Efficacy of intravitreal injection of bevacizumab for severe retinopathy of prematurity: a pilot study. Br. J. Ophthalmol. 2008, 92(11):1450-1455.
-
(2008)
Br. J. Ophthalmol.
, vol.92
, Issue.11
, pp. 1450-1455
-
-
Kusaka, S.1
Shima, C.2
Wada, K.3
Arahori, H.4
Shimojyo, H.5
Sato, T.6
Fujikado, T.7
-
4
-
-
0025189996
-
The relationship of puberty to diabetic retinopathy
-
Murphy R.P., Nanda M., Plotnick L., Enger C., Vitale S., Patz A. The relationship of puberty to diabetic retinopathy. Arch. Ophthalmol. 1990, 108(2):215-218.
-
(1990)
Arch. Ophthalmol.
, vol.108
, Issue.2
, pp. 215-218
-
-
Murphy, R.P.1
Nanda, M.2
Plotnick, L.3
Enger, C.4
Vitale, S.5
Patz, A.6
-
5
-
-
62549101271
-
Intravitreal bevacizumab (Avastin) for primary treatment of diabetic macular oedema
-
Özkirş A. Intravitreal bevacizumab (Avastin) for primary treatment of diabetic macular oedema. Eye 2009, 23(3):616-620.
-
(2009)
Eye
, vol.23
, Issue.3
, pp. 616-620
-
-
Özkirş, A.1
-
6
-
-
0036480152
-
Review: coats disease: The 2001 LuEsther T. Mertz lecture
-
Shields J.A., Shields C.L. Review: coats disease: The 2001 LuEsther T. Mertz lecture. Retina 2002, 22:80-91.
-
(2002)
Retina
, vol.22
, pp. 80-91
-
-
Shields, J.A.1
Shields, C.L.2
-
7
-
-
34548022138
-
Elevated vascular endothelial growth factor levels in Coats disease: rapid response to pegaptanib sodium
-
Sun Y., Jain A., Moshfeghi D.M. Elevated vascular endothelial growth factor levels in Coats disease: rapid response to pegaptanib sodium. Graefes Arch. Clin. Exp. Ophthalmol. 2007, 245:1387-1388.
-
(2007)
Graefes Arch. Clin. Exp. Ophthalmol.
, vol.245
, pp. 1387-1388
-
-
Sun, Y.1
Jain, A.2
Moshfeghi, D.M.3
-
8
-
-
78650830753
-
Intravitreal bevacizumab (Avastin) in a pediatric case of pathologic myopia
-
Sundaram, Natarajan D.O., Uparkar, Mahesh M.S., Athale, Ashish M.S., Mahindrakar, Aniruddha M.S. Intravitreal bevacizumab (Avastin) in a pediatric case of pathologic myopia. Retinal Cases & Brief Reports 2007, 1(4):192-194.
-
(2007)
Retinal Cases & Brief Reports
, vol.1
, Issue.4
, pp. 192-194
-
-
Sundaram Natarajan, D.O.1
Uparkar Mahesh, M.S.2
Athale Ashish, M.S.3
Mahindrakar Aniruddha, M.S.4
-
9
-
-
42049110754
-
Management of Coats disease with bevacizumab in 2 patients
-
Venkatesh P., Mandal S., Garg S. Management of Coats disease with bevacizumab in 2 patients. Can. J. Ophthalmol. 2008, 43:245-246.
-
(2008)
Can. J. Ophthalmol.
, vol.43
, pp. 245-246
-
-
Venkatesh, P.1
Mandal, S.2
Garg, S.3
|